Form D · Biotechnology
Nexsis Biosciences LLC
St. Augustine, FL · CIK 0002028035
Offering snapshot reported Jun 24, 2024 · SEC filing
- Reported sold
- $725K Offering amount: $725K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2024 | Initial | $725,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516690
Source: Form D, filed Jun 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Cart | Director, Executive |
| Beecher Lewis | Director, Executive |
| John Pirris | Director |
| John C. Thomas, Jr. | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
186 Silver Sage Lane
St. Augustine, FL, 32095
St. Augustine, FL, 32095